UBE2D4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.484000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.469800E-01
Normal-vs-Stage2
5.811400E-01
Normal-vs-Stage3
3.965600E-01
Normal-vs-Stage4
8.279400E-01
Stage1-vs-Stage2
1.675400E-01
Stage1-vs-Stage3
9.021800E-02
Stage1-vs-Stage4
9.533400E-01
Stage2-vs-Stage3
2.663600E-01
Stage2-vs-Stage4
2.887600E-01
Stage3-vs-Stage4
1.846630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.038600E-01
Normal-vs-AfricanAmerican
7.980000E-01
Normal-vs-Asian
7.450400E-01
Caucasian-vs-AfricanAmerican
2.231600E-01
Caucasian-vs-Asian
9.520200E-01
AfricanAmerican-vs-Asian
4.207000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.312400E-01
Normal-vs-Female
6.857400E-01
Male-vs-Female
8.083000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.741000E-01
Normal-vs-Age(41-60Yrs)
7.922000E-01
Normal-vs-Age(61-80Yrs)
5.916400E-01
Normal-vs-Age(81-100Yrs)
5.453400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.916200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.815600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.186400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.745000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.861400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.538000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.192000E-01
Normal-vs-Daily Drinker
3.485000E-01
Normal-vs-Weekly Drinker
4.838000E-01
Normal-vs-Occasional Drinker
8.470800E-01
Normal-vs-Social Drinker
8.249400E-01
Non Drinker-vs-Daily Drinker
8.644400E-01
Non Drinker-vs-Weekly Drinker
5.412800E-01
Non Drinker-vs-Occasional Drinker
1.365960E-01
Non Drinker-vs-Social Drinker
2.318000E-02
Daily Drinker-vs-Weekly Drinker
6.457800E-01
Daily Drinker-vs-Occasional Drinker
1.979790E-01
Daily Drinker-vs-Social Drinker
4.040200E-02
Weekly Drinker-vs-Occasional Drinker
4.390400E-01
Weekly Drinker-vs-Social Drinker
1.340040E-01
Occasional Drinker-vs-Social Drinker
4.402600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.120800E-01
Normal-vs-Grade 2
4.164000E-02
Normal-vs-Grade 3
7.568000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.040400E-01
Grade 1-vs-Grade 3
2.652000E-01
Grade 1-vs-Grade 4
1.120800E-01
Grade 2-vs-Grade 3
3.677400E-01
Grade 2-vs-Grade 4
4.164000E-02
Grade 3-vs-Grade 4
7.568000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.499400E-01
Normal-vs-NonDiabetic
6.313600E-01
Diabetic-vs-NonDiabetic
4.300400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.202800E-01
Normal-vs-NoPancreatitis
6.261200E-01
Pancreatitis-vs-NoPancreatitis
6.888000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.150800E-01
Normal-vs-N1
6.461600E-01
N0-vs-N1
7.541400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.216200E-01
Normal-vs-TP53-NonMutant
9.878000E-01
TP53-Mutant-vs-TP53-NonMutant
3.519300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
